{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T10:54:09Z","timestamp":1762685649538,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/EMEQ-064\/2014"],"award-info":[{"award-number":["SB\/EMEQ-064\/2014"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UPE-2"},{"DOI":"10.13039\/501100001501","name":"UGC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"CSIR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijbiomac.2019.05.075","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T20:59:25Z","timestamp":1557867565000},"page":"645-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Role of Herborn (K240E) and Milano Slow (D375H) human serum albumin variants towards binding of phenylbutazone and ibuprofen"],"prefix":"10.1016","volume":"134","author":[{"given":"Aparna","family":"Nerusu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Kumar","family":"Chinthapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajagopal","family":"Subramanyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1996","series-title":"All About Albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters","key":"10.1016\/j.ijbiomac.2019.05.075_bb0005"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/chir.20709","article-title":"Ligand binding strategies of human serum albumin: how can the cargo be utilized?","volume":"22","author":"Varshney","year":"2010","journal-title":"Chirality"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0025","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1016\/j.bbagen.2013.03.015","article-title":"Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes","volume":"1830","author":"Kragh-Hansen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0035","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/bip.22096","article-title":"About the structural role of disulfide bridges in serum albumins: evidence from protein simulated unfolding","volume":"97","author":"Paris","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bpc.2010.03.001","article-title":"Allostery in a monomeric protein: the case of human serum albumin","volume":"148","author":"Ascenzi","year":"2010","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0045","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1423-0410.2002.tb05326.x","article-title":"Beyond expansion: structural studies on the transport roles of human serum albumin","volume":"83","author":"Curry","year":"2002","journal-title":"Vox Sang."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2133\/dmpk.24.342","article-title":"Lessons from the crystallographic analysis of small molecule binding to human serum albumin","volume":"24","author":"Curry","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0065","first-page":"160","article-title":"Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands","volume":"34","author":"Kragh-Hansen","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0167-4838(96)00013-1","article-title":"Characterization of site I on human serum albumin: concept about the structure of a drug binding site","volume":"1295","author":"Yamasaki","year":"1996","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/(SICI)1520-636X(1997)9:7<643::AID-CHIR1>3.0.CO;2-8","article-title":"Stereoselectivity and enantiomer-enantiomer interactions in the binding of ibuprofen to human serum albumin","volume":"9","author":"Itoh","year":"1997","journal-title":"Chirality"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0080","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1016\/j.bbagen.2013.03.026","article-title":"Human serum albumin isoforms: genetic and molecular aspects and functional consequences","volume":"1830","author":"Kragh-Hansen","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0085","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.bbapap.2007.09.001","article-title":"Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albumin","volume":"1774","author":"Iwao","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbapap.2004.09.025","article-title":"Effect of genetic variation on the thermal stability of human serum albumin","volume":"1747","author":"Kragh-Hansen","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cccn.2004.06.013","article-title":"Structural analysis and fatty acid-binding properties of two Croatian variants of human serum albumin","volume":"349","author":"Kragh-Hansen","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3010217","article-title":"Modified high-affinity binding of Ni2+, Ca2+ and Zn2+ to natural mutants of human serum albumin and proalbumin","volume":"301","author":"Kragh-Hansen","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1432-1033.1990.tb19319.x","article-title":"Hormone binding to natural mutants of human serum albumin","volume":"193","author":"Kragh-hansen","year":"1990","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1432-1033.1993.tb17939.x","article-title":"The structural characterization and bilirubin-binding properties of albumin Herborn, a [Lys240\u2192Glu] albumin mutant","volume":"214","author":"Minchiotti","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0115","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1432-1327.1998.2510329.x","article-title":"Structural characterization of three genetic variants of human serum albumin modified in subdomains IIB and IIIA","volume":"251","author":"Galliano","year":"1998","journal-title":"Eur. J. Biochem."},{"year":"2010","series-title":"Invitrogen: EasySelect\u2122 Pichia Expression Kit, Manual Part No. 25-0172","key":"10.1016\/j.ijbiomac.2019.05.075_bb0120"},{"year":"2010","series-title":"Invitrogen: pPIC9K, a Pichia Vector for Multicopy Integration and Secreted Expression Catalog No. V175\u201320","key":"10.1016\/j.ijbiomac.2019.05.075_bb0125"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijbiomac.2018.05.129","article-title":"Applicability of endochitinase of Flavobacterium johnsoniae with transglycosylation activity in generating long-chain chitooligosaccharides","volume":"117","author":"Vaikuntapu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-1119(94)90641-6","article-title":"Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction","volume":"151","author":"Weiner","year":"1994","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02942184","article-title":"Fermentation strategies for recombinant protein expression in the methylotrophic yeast Pichia pastoris","volume":"5","author":"Zhang","year":"2000","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1389-1723(00)88050-0","article-title":"High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation","volume":"89","author":"Kobayashi","year":"2000","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0155","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1021\/acsomega.7b00577","article-title":"Unraveling the stability of plasma proteins upon interaction of synthesized androstenedione and its derivatives - a biophysical and computational approach","volume":"2","author":"Nerusu","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0160","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/07391102.2014.947326","article-title":"Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and \u03b1-1-acid glycoprotein","volume":"33","author":"Yeggoni","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jphotobiol.2008.09.002","article-title":"Betulinic acid binding to human serum albumin: a study of protein conformation and binding affinity","volume":"94","author":"Subramanyam","year":"2009","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0170","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1039\/C4MB00635F","article-title":"Comparative binding mechanism of lupeol compounds with plasma proteins and its pharmacological importance","volume":"11","author":"Kallubai","year":"2015","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0175","series-title":"Principles of Fluorescence Spectroscopy","first-page":"277","author":"Lakowicz","year":"2009"},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0180","doi-asserted-by":"crossref","first-page":"49439","DOI":"10.1039\/C5RA04395F","article-title":"Quantum molecular modelling of ibuprofen bound to human serum albumin","volume":"5","author":"Dantas","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0185","doi-asserted-by":"crossref","first-page":"32358","DOI":"10.1039\/C6CP05680F","article-title":"Multiple binding modes of ibuprofen in human serum albumin identified by absolute binding free energy calculations","volume":"18","author":"Evoli","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2019.05.075_bb0190","doi-asserted-by":"crossref","first-page":"11677","DOI":"10.1021\/ja800966t","article-title":"Ibuprofen induces an allosteric conformational transition in the heme complex of human serum albumin with significant effects on heme ligation","volume":"130","author":"Nicoletti","year":"2008","journal-title":"J. Am. Chem. Soc."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019314187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019314187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:42:35Z","timestamp":1568940155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019314187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":38,"alternative-id":["S0141813019314187"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.05.075","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Herborn (K240E) and Milano Slow (D375H) human serum albumin variants towards binding of phenylbutazone and ibuprofen","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.05.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}